GenoFAB works with life scientists who need plasmids to develop the next-generation biotechnology products or test groundbreaking scientific hypotheses.
GenoFAB biofoundry combines data science and automation to manage plasmids from design to distribution.
Unlike internally developed plasmids that are partially documented, poorly designed, contain mutations and are difficult to distribute securely, GenoFAB uses software to automate the design, documentation, assembly, production, and distribution of plasmids you can trust.
GenoFAB, Inc. is a spin-off of Colorado State University (CSU) that has licensed patented technologies developed with funding from the National Institutes of Health, the National Science Foundation, and other federal agencies. Through a contract with CSU, GenoFAB also has access to the services of the Colorado Biofoundry to subcontract part of its clients projects to a high-throughput facility that complements their internal laboratory resources.
At GenoFAB, our 'data first' philosophy is more than a belief. It's a strategic approach that underlines the importance of data as a foundational element in the decision-making, development, and operations of R&D projects. This core principle is designed to maximize shareholder value by supporting strong patent claims while ensuring freedom to operate.
The GenoFAB patent-pending Biofoundry Operating System is not just a tool. It's a powerful platform that provides unprecedented flexibility, empowering you to manage complex R&D projects. It allows you to define and manage complex workflows that combine experimental steps, computational operations, and supply chain transactions, putting you firmly in control of your projects.
